Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

March 31, 2021

Conditions
Multiple MyelomaNeoplasmsPlasma CellsParaproteinemiasBlood Protein DisordersHematologic DiseasesTherapeutic Uses
Interventions
DRUG

Lenalidomide

Treatment with lenalidomide capsules 10 mg, 5mg daily or 5mg every other day given on days 1-21 of each 28 day cycle.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY